Shopping Cart
- Remove All
Your shopping cart is currently empty
KRM-III is an orally active T cell antigen receptor (TCR) inhibitor with anti-inflammatory activity that potently inhibits TCR and myristate acetate/fosfomycin/ionomycin-induced NFAT nuclear factor activation and T cell proliferation, with an IC50 of approximately 5 μM.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 2 mg | $30 | In Stock | |
| 5 mg | $51 | In Stock | |
| 10 mg | $81 | In Stock | |
| 25 mg | $173 | In Stock | |
| 50 mg | $258 | In Stock | |
| 100 mg | $368 | In Stock | |
| 200 mg | $506 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $56 | In Stock |
| Description | KRM-III is an orally active T cell antigen receptor (TCR) inhibitor with anti-inflammatory activity that potently inhibits TCR and myristate acetate/fosfomycin/ionomycin-induced NFAT nuclear factor activation and T cell proliferation, with an IC50 of approximately 5 μM. |
| Targets&IC50 | Proliferation (T-cells):~5 μM |
| Molecular Weight | 252.33 |
| Formula | C15H12N2S |
| Cas No. | 79220-94-3 |
| Smiles | S=c1[nH]c(cn1-c1ccccc1)-c1ccccc1 |
| Color | White |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 25.23 mg/mL (100 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.